Does OLUTASIDENIB Cause Unevaluable event? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Unevaluable event have been filed in association with OLUTASIDENIB (REZLIDHIA). This represents 2.9% of all adverse event reports for OLUTASIDENIB.
6
Reports of Unevaluable event with OLUTASIDENIB
2.9%
of all OLUTASIDENIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Unevaluable event From OLUTASIDENIB?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLUTASIDENIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does OLUTASIDENIB Cause?
Off label use (59)
Hospitalisation (27)
Death (24)
Nausea (23)
Fatigue (21)
Product dose omission issue (19)
Product prescribing issue (15)
Constipation (14)
Transfusion (11)
Pneumonia (9)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which OLUTASIDENIB Alternatives Have Lower Unevaluable event Risk?
OLUTASIDENIB vs OMACETAXINE MEPESUCCINATE
OLUTASIDENIB vs OMADACYCLINE
OLUTASIDENIB vs OMALIZUMAB
OLUTASIDENIB vs OMAVELOXOLONE
OLUTASIDENIB vs OMBITASVIR